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Increasing the activity and efficiency of stereoselective 
oxidations using decoy molecules in combination with rate 
enhancing variants of P450Bm3 
Samuel D. Munday,[a] Shaghayegh Dezvarei,[a] and Stephen G. Bell*[a] 
 
Abstract: The use of rate accelerating variants of P450Bm3 coupled 
with decoy molecules is described resulting in improved catalytic 
activity of hydroxylation and epoxidation reactions. Prochiral 
substrates were investigated to ascertain the effect of the mutant 
enzymes and the decoy molecules on the regio- and enantio-
selectivity of the oxidations. For the alkyl and alkene substituted 
benzene substrates tested large improvements in the product 
formation activity over the wild-type enzyme were obtained. The 







for variants containing the R47L and 
Y51F mutations. While the regioselectivity was not significantly 
altered in most of the turnovers some adjustment in the 
enantioselectivity was observed with the smaller substrates. The 
addition of decoy molecules often resulted in improved 
enantioselectivity and counteracted reductions arising from the rate 
accelerating mutants. 
Introduction 
Cytochrome P450s (CYPs) are heme-dependent enzymes which 
are able to insert a single oxygen atom from molecular dioxygen 
into a carbon–hydrogen bond to give the corresponding alcohol 
or oxidise an alkene to yield an epoxide.[1] Nature has evolved 
many of these enzymes so that these reactions occur with total 
regio- and stereoselectivity.[2] The selective hydroxylation of 
unactivated CH bonds by chemical methods is energy-intensive, 
non-selective and generates unwanted side products and toxic 
wastes. Biocatalytic asymmetric epoxidations are also of great 
interest. These CYP-mediated oxidation reactions have the 
potential to provide efficient biocatalyts for stereoselective 
oxidations to form alcohols and epoxides.[3]  
CYP102A1 (P450Bm3) from Bacillus megaterium is a self-
sufficient enzyme in which the electron transfer reductase domain 
is fused to the heme domain.[3b] It is soluble, easy to produce and 
requires only a substrate, NADPH and oxygen to operate. Its 
active state is a dimer which is capable of hydroxylating fatty acid 
substrates, at sub-terminal positions, with unusually high 
activity.[4] The fusion protein nature and high activity of P450Bm3 
overcome two the major hurdles to the use of these enzymes in 
synthesis.[3b, 5] Wild-type P450Bm3 (WT) oxidises the majority of 
unnatural substrates at very slow rates if at all. However it has 
been used as a template for the design of biocatalysts through 
protein engineering.[3a, 3b, 6] These studies have resulted in 
variants which are capable of selective oxidation reactions and 
recently even non-physiological functions such as 
cyclopropanation, amination and aziridination have been 
engineered into this enzyme.[6f, 7] 
P450Bm3 variants, such as I401P and KT2 
(A191T/N239H/I259V/A276T/L353I) have been identified, which 
enhance activity for unnatural substrate oxidation but maintain the 
product regioselectivity of the WT enzyme.[6a, 8] The substrate free 
forms of these generic accelerator mutants have been shown to 
have conformations which are more similar to the fatty acid bound 
form of the enzyme (PDB: 1JPZ).[9] This is especially true in 
important regions such as the I helix which is involved in the 
mechanism of oxygen binding and cleavage to generate the 
reactive intermediate.[6a, 8a] In the crystal structure of the 
substrate-free form of the KT2 (PDB: 3PSX) and I401P (PDB: 
3HF2) variants the heme axial water interactions were weakened. 
Kinetic studies also showed that the rate of the first electron 
transfer step for these variants in the absence of substrate were 
comparable to that when substrate is bound. Therefore it has 
been proposed that KT2 and I401P have catalytically ready 
conformations, such that substrate-induced changes to the 
structure play a less significant role in promoting the electron 
transfer steps resulting in its ability to oxidise non-natural 
substrates at elevated rates. 
Other variants include the R47L/Y51F (RLYF) mutant of 
P450Bm3 which has been shown to promote the oxidation of a 
range of unnatural substrates.[6a, 10] It has been hypothesised that 
the RLYF couple allows better recognition and entry of more 
hydrophobic substrates. Mutations at these sites are known to 
reduce the affinity for the fatty acid substrate. However this pair of 
amino acids is not conserved in many other members of the 
CYP102A subfamily which bind and hydroxylate fatty acids.[11] 
The RLYF couple has been added to rate accelerating P450Bm3 
variants and has been found to further enhance their activity.[6a, 8a, 
8b] For example the variant R19 
( R47L/Y51F/H171L/Q307H/N319Y) has the RLYF couple to 
KSK19 variant (minus the F87A mutation).[12] The RLYFIP 
(R47L/Y51F/I401P) variant contains the I401P mutant which is on 
the proximal side of the heme and is known to be an effective rate 
accelerating variant for several substrates.[8a, 8b] 
In an alternative approach to improve the activity of P450 
enzymes, chemically inert perfluorocarboxylic acids (PFCs) have 
been used as decoy molecules.[13] These greatly promote the 
oxidation of unnatural substrates such as benzenes, xylenes and 
short chain alkanes. They work as the inert decoy fills part of the 
enzyme’s active site causing conformational changes in the 
enzyme and constraining substrates to bind closer to the heme.[14] 
The structure of a PFC9-L-Trp-bound WT (PDB: 3WSP) showed 
that the decoy molecule (the N-perfluoroacyl amino acid, PFC9-
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L-Trp) filled the access channel but left enough space close to the 
heme to bind a substrate. These enzyme-substrate interactions in 
the vicinity of the heme remain relatively unaffected allowing the 
reaction to proceed with the same selectivity of product formation.  
It has been shown that incorporating the use of the decoy 
molecules, perfluoroctanoic (PFC8), perfluorononanoic (PFC9) 
and perfluorodecanoic (PFC10) acids, with WT and KT2 
P450Bm3 significantly improves the rates of product formation for 
cyclohexane and several benzene-derived substrates. 
Importantly the turnovers with KT2 were more active and the 
product profiles of the oxygenated substrates remained 
predominantly unchanged.[15] The mechanisms by which decoy 
molecules and the rate accelerating variants show enhanced 
unnatural substrate activity are different but work in concert to 
facilitate the oxidation of organic molecules. Here we investigate 
the effect of the rate accelerating variants and decoy molecules 
on the stereoselectivity of alcohol and epoxide formation by 
utilising substrates that are known to be oxidised to products 
which contain a stereocentre. 
Results  
Ethylbenzene and n-propylbenzene 
Although they do not resemble the fatty acid substrates, 
ethylbenzene and n-propylbenzene are known to be oxidised by 
WT and KT2 P450Bm3 with high selectivity (Scheme 1).[6a, 16] 
They are hydroxylated at the benzylic (or ) CH bonds with o-
hydroxylation resulting as a minor product  for each (Scheme 1). 
In addition, WT P450Bm3 is known to be relatively stereoselective 
in its oxidation of n-propylbenzene producing (R)-1-phenyl-1-
propanol in excess over the (S) enantiomer (reported as an 
enantiomeric excess of: 90%).[16a] Ethylbenzene and n-
propylbenzene were both oxidised by WT and KT2 P450Bm3 in 
the presence and the absence of PFC decoy molecules (Fig. 1, 
Table S1). n-Propylbenzene was turned over with a product 
formation rate (PFR) of 368 nmol.(nmol P450)-1.min-1 (henceforth 
given as min-1).[6a, 16b] The WT/PFC9 combination increased the 
PFR by 4-fold over the WT reaction due to an increase in the rate 
of NADPH consumption as well as coupling efficiency (defined as 
the percentage of NADPH reducing equivalents used in 
productive oxidation of the substrate). KT2, being in a catalytically 
ready conformation, oxidised n-propylbenzene three times faster 
than WT (Fig. 1, Table S1). The combination of this enzyme and 
PFC10 was the optimum of those tested, being almost double that 
of KT2 (Fig. 1). Overall, the combination of PFC10 with KT2 
improved the rate of oxidation of n-propylbenzene by 5.5-fold over 
the WT enzyme (Fig. 1, Table 1).  
The oxidation of ethylbenzene by the WT enzyme was 
significantly slower than n-propylbenzene (3.8 min-1). 
Incorporating PFC9 into the reaction improved the rate by 215-
fold by augmentation of both the NADPH consumption rate and 
the coupling efficiency (Fig. 1, Table S1). KT2 oxidised 
ethylbenzene faster than the WT enzyme and when used in 
combination with PFC9 the product formation rate was 350-fold 
greater than the WT enzyme alone (Fig. 1). For both 
alkylbenzenes, the faster NADPH oxidation rate of KT2 was the 
key contributor to increased PFRs, as the coupling efficiency of 
the best WT and KT2 decoy molecule combinations were similar 
(Fig. 1, Table S1). 
The oxidation products were identified by GC-MS coelution 
experiments with authentic standards where available. WT and 
KT2 P450Bm3 in the presence and absence of decoys primarily 
oxidised ethylbenzene and n-propylbenzene at the benzylic () 
position to give 1-phenyl-1-ethanol (-Et, 83-92%,) and 1-phenyl-
1-propanol (-Pr, 91-94%) as the major products (Scheme 1, Fig. 
2, Table S2). Minor products for both substrates were observed 
as a result of o-hydroxylation on the aromatic ring and for n-
propylbenzene from hydroxylation of the β-position of the alkyl 
chain (2-4%, Scheme 1, Table S2). No hydroxylation of the 
terminal alkyl carbon was observed for either substrate nor was 
any desaturation product identified for ethylbenzene which has 
been observed for some P450Bm3 variants.[16b] There was also 
the presence of a small amount of a ketone over-oxidation product 
of -Pr in the n-propylbenzene turnovers (-ket-Pr,1-2%). 
Oxidation of either substrate at the -position to give the 
hydroxylated product introduces a chiral centre (Scheme 1).  
 
Scheme 1. Product distributions of catalysed oxidation of ethylbenzene, 
n-propylbenzene, styrene and trans-β-methylstyrene in the presence and 
absence of decoy molecules. The products from ethylbenzene: 1-
phenylethanol (α-Et) and 2-ethylphenol (o )-Et; from n -propylbenzene: 1-
phenyl-1-propanol (α-Pr), 1-phenyl-2-propanol (β-Pr), 2-propylphenol (o )-
Pr and propiophenone (α-ket-Pr); from styrene: styrene oxide; and from 
trans-β-methylstyrene: 1-phenylpropylene oxide (β-oxide). The values in 
italics represent the ratio of the (R)- and (S)-enantiomers of 1-
phenylethanol, 1-phenyl-1-propanol and  styrene oxide. For 1-
phenylpropylene oxide, the values in italics represent the ratio of the 
(R,R) and (S,S) enantiomers of 1-phenylpropylene oxide. The values in 
bold are the enantiomeric excess (ee). 






Figure 1. NADPH activity (black filled) and PFR (lined) of WT P450Bm3 and 
the rate accelerating variants; KT2, R19 and RLYFIP (RP) with (a) 
ethylbenzene, (b) n - propylbenzene, (c) styrene and (d) trans-β -
methylstyrene in the presence and absence of decoy molecules. The 
coupling efficiency is the ratio of the PFR to NADPH activity (Table S1). 
The chiral benzylic hydroxylation products were assigned by 
coelution experiments using a chiral GC column. WT and KT2 
P450Bm3 were mostly selective for the (R)-enantiomer in the 
absence and presence of decoys (α-ET, 48% ee and α-Pr 74% 
ee). n-Propylbenzene was also oxidised predominantly to the (R)-
enantiomer of -Pr and the enantiomeric excess (ee) was greater 
those of the equivalent ethylbenzene turnovers (Fig. 2, Fig. S1 Fig. 
S2, Table S2).  
WT oxidation of ethylbenzene was more enantioselective than 
KT2. The greatest enantiomeric excess of (R)--Et formed with 
WT P450Bm3 was 62% compared to 34% with KT2 (both using 
PFC10, Fig. S1). WT and KT2 both displayed similar selectivity 
for (R)-α-Pr but the PFC9 and PFC10 decoys resulted in slightly 
more selective combinations for both (Fig. 2, Fig. S1, Table S2). 
The maximum enantiomeric excess of the (R)-α-Pr formed was 
80% for WT and 72% for KT2 when decoy molecules were used 
(Table S2). These results agree with previous studies which also 
observed the (R)-isomer being produced in large excess by WT 
P450Bm3 (Fig. 2, Table S2).[16a]  
Styrene and trans-β-methylstyrene 
Styrene has previously been reported to be a poor substrate for 
WT P450Bm3 but other variants epoxidise this substrate to give 
styrene oxide as the major product. Mutations at the Ala82 and 
Thr438 residues have been shown to be effective in encouraging 
styrene oxidation.[17] The P450Bm3 variant A82F/T438F, which 
contains a more restricted active site, oxidised styrene to give the 
(R)-enantiomer of the epoxide in an enantiomeric excess of 64%. 
trans-β-Methylstyrene has also been trialled as a substrate with 
the KT2 variant and was oxidised at the double bond to give the 
epoxide mostly as the (R)-isomer (reported ee: 88%).[18] 
The KT2 combinations oxidised both substrates at higher 
activities than the equivalent WT reaction in every circumstance. 
Overall, both styrene substrates were oxidised at slower rates 
than their alkylbenzene counterparts (Fig. 1, Table S1). The 
addition of PFC9 generated the most efficiently coupled reactions 
and PFC10 induced the highest NADPH activity but a lower 
coupling efficiency.  






Figure 2. GC-MS analyses of (a) WT (grey) and WT/PFC9 (black) with 
ethylbenzene; (b) WT and WT/PFC9 with n-propylbenzene; (c) chiral GC 
analysis of the 1-phenylethanol product in the turnovers with RLYF/PFC10 
(solid) R19/PFC10 (dash) and R19 (dash/dot) and (d) chiral GC analysis 
of the 1-phenyl-1-propanol product in the turnovers with KT2 (black) 
KT2/PFC10 (dash) and RLYFIP/PFC10 (dash/dot). The internal standard 
is labelled when shown (IS) as are impurities (*). 
The inclusion of PFC9 in the WT-catalysed oxidation of styrene 
resulted in a 73-fold increase in PFR whereas PFC10 improved 
the rate by 91-fold due to the superior NADPH consumption rate 
(Fig. 1 and Table S1). The best improvement with a decoy and 
the KT2 variant was obtained using PFC9 increasing the PFR by 
almost 12-fold over KT2 alone. The overall improvement of 
styrene oxidation was 140-fold when using KT2/PFC9 over WT 
(Fig. 1, Table S1). 
trans-β-Methylstyrene was oxidised at faster rates than styrene 
for all the combinations. For the WT enzyme/decoy molecule 
combinations, the greatest improvement was observed with 
PFC10 (41-fold increase in PFR) due to a smaller reduction in 
coupling efficiency, compared to PFC9 combined with the fastest 
NADPH activity. For KT2, PFC9 was the optimum sized decoy, 
resulting in an almost 3-fold improvement in the PFR over KT2 
alone. The coupling efficiency of the KT2/PFC9 turnover was 18% 
greater than the KT2/PFC10 system and was the most active 
combination for this substrate. Overall, the KT2/PFC9 system 
improved the oxidation activity of trans-β-methylstyrene by 61-fold 
over the WT enzyme alone (Fig. 1, Table S1). 
The WT and KT2 catalysed oxidation of both substrates was 
highly regioselective, with a major single product arising from both 
(Scheme 1, Fig. 3, Table S2). Both were epoxidised at the double 
bond to yield styrene oxide (phenyloxirane) and 1-
phenylpropylene oxide (β-oxide), respectively. Small amounts 
(~1%) of a second product arose in styrene turnovers, which from 
coelution experiments was assigned as phenylacetaldehyde.[19] 
Small peaks (<1% of total product) which coeluted phenylacetone 
and propiophenone were observed in the P450Bm3 catalysed 
oxidation of trans-β-methylstyrene. No variation in the 
regioselectivity was observed for any of the enzyme/decoy 
combinations.  
Styrene oxide, which contains a single stereocentre, was mostly 
generated as the (R)-stereoisomer with the enantiomeric excess 
ranging from 14-32% (Fig. 3, Fig. S1 and Table S2). WT 
P450Bm3 epoxidation was more stereoselective than KT2 (18% 
vs 14% ee) and the inclusion of decoys improved the 
enantiomeric excess of the (R)-isomer of both (up to 32% ee, 
Table S2). Epoxidation of trans-β-methylstyrene introduced two 
stereocentres. Both WT and KT2 were highly selective for the 
(R,R) isomer over the (S,S) and this oxidation was more 
stereoselective (70% ee) compared to that of styrene (Fig. 3, Fig 
S1, Table S2). The results were in general agreement with those 
previously reported with KT2.[18] Unlike the oxidation of styrene 
there was little variation in stereoselectivity between the WT and 
KT2 enzymes, nor did introducing decoys significantly alter the 
enantiomeric excess (Fig. 3d, Table S2). 






Figure 3. GC analyses of (a) WT with styrene (grey) and WT/PFC9 with 
styrene (black); (b) GC-MS analyses of WT and WT/PFC9 with trans-β-
methylstyrene; (c) chiral GC analysis of the styrene oxide product in the 
turnovers with KT2 (black) KT2/PFC10 (dotted) and RLYFIP (dash) and 
(d) chiral GC analysis of the 1-phenylpropylene oxide product in the 
turnovers with KT2/PFC10 (dashed) and R19/PFC10 (black). The internal 
standard is labelled when shown (IS) as are impurities (*). 
Rate accelerating variants incorporating the R47L/Y51F 
couple 
The above results show that the activity of P450Bm3 can be 
enhanced by adding fatty acid based decoy molecules to the WT 
enzyme and rate accelerating variant KT2. We wanted to assess 
if decoy molecules could be used to enhance the oxidation of 
unnatural products when combined with highly active rate 
enhancing variants which contain mutations at the R47 and Y51 
residues. The arginine and tyrosine are known to interact with the 
acidic group of the fatty acids.[20] This pair of mutations would be 
expected to promote the oxidation of non-natural substrates but 
could potentially lower the affinity for the fatty acid decoy 
molecules. For all four substrates the activity of product formation 
decreased in the order RLYFIP > R19 > KT2 > WT (Fig. 1, Table 
S1). In all instances both the NADPH oxidation activity and the 
coupling efficiency was greater for the variants containing the 
R47L/Y51F couple. The RLYFIP variant was better than R19 
predominantly due to an increased NADPH oxidation rate even 
though its coupling efficiency was often lower (Fig. 1, Table S1). 
The turnovers of n-propylbenzene and trans-β-methylstyrene with 
R19 and RLYFIP alone were better than the optimal KT2/PFC 
decoy molecule combinations (Fig. 1, Table S1).  
The oxidation of the smaller ethylbenzene and styrene substrates 
were both enhanced by adding PFC10 to the R19 and RLYFIP 
turnovers. In the case of ethylbenzene this was due to an increase 
in the coupling efficiency but the overall activity of product 
formation was similar to that observed with the KT2/PFC9 
combination. With styrene there was an increase in both the 
NADPH oxidation activity and coupling efficiency when PFC10 
was used as a decoy molecule (Fig. 1, Table S1). There was 
significant improvement over the most active KT2 turnover with 
the rate enhancement of the RLYFIP/PFC10 combination being 
410-fold more active than the WT enzyme alone (Fig. 1, Table S1). 
The addition of the decoy molecule PFC10 to the turnovers of n-
propylbenzene with R19 or RLYFIP did not result in a significant 
increase in the product formation activity which was already high 
(Fig. 1, Table S1). Similarly there was no increase in activity with 
trans-β-methylstyrene with the RLYFIP/PFC10 combination. 
However the addition of PFC10 to R19 did enhance trans-β-
methylstyrene oxidation mainly through an increase in the rate of 
NADPH oxidation (Fig. 1). The epoxidation activities were 
enhanced over the KT2 combinations and the improvements over 
the WT enzyme alone for the R19 and RLYFIP mutants when 
using PFC10 as a decoy were both greater than 130-fold.  
These combinations resulted in the highest product formation 
rates for the different substrates ranging from 661 min1 for 






styrene, 1270 min1 for trans-β-methylstyrene to 2210 min1 for n-
propylbenzene (Fig. 1, Table S1). 
The regioselectivities of styrene and trans-β-methylstyrene 
oxidation were unchanged compared to the WT and KT2 
turnovers with epoxidation being the sole major product (>98%). 
The same was true for n-propylbenzene oxidation with 1-phenyl-
1-propanol being the major product. More further oxidation to the 
α-ketone occurred in the R19 and RLYFIP turnovers, however the 
selectivity for the -position was ≥ 98% (Table S2). The 
regioselectivity of oxidation of ethylbenzene by R19 (82% α-Et) 
was similar to KT2 in that both were less selective than the WT 
(Table S2) in generating 1-phenylethanol as the major product. 
By way of contrast the RLYFIP variant was marginally more 
selective producting 91% of 1-phenylethanol. In both instances 
the addition of the PFC10 decoy molecule moderately increased 
the selectivity for the major product (Table S2). 
The trends in enantioselectivity were more complex for the R19 
and RLYFIP variants. The enantioselectivity for trans-β-
methylstyrene oxidation was virtually unchanged across all of the 
variants and decoy molecule combinations though it was 
marginally lower for the turnovers with RLYFIP (70% vs. 75% ee, 
Table S2). The enantioselectivity of the 1-phenyl-1-propanol 
product in the R19 and RLYFIP turnovers was similar to the KT2 
combinations though slightly lower than those of the WT (68-70% 
vs. 74-80% ee, Table S2). We note that the higher levels of the 
ketone further oxidation product may affect the results by 
favouring the oxidation of one enantiomer of the alcohol over the 
other. Larger changes were observed with the smaller substrates. 
With ethylbenzene the preference for the R-enantiomer product 
with R19 (27% ee) was similar to KT2 (22% ee) while that of 
RLYFIP (51% ee) was more like the WT enzyme (48% ee) in 
having a larger enantiomeric excess (Table S2). The 
enantioselectivity of styrene oxide formation was lower for R19 
(25% ee) while RLYFIP formed an almost equal mixture of both 
enantiomers (6% ee, Fig. 3c and Table S2). Importantly for both 
ethylbenzene and styrene turnovers the decoy molecule PFC10 
increased the enantioselectivity of the turnover in line with what 
was observed for the WT and KT2 turnovers. This resulted in an 
improved ee of 62% for ethylbenzene hydroxylation by 
RLYFIP/PFC10 and 31% for styrene oxide formation by 
R19/PFC10 (Table S2). 
Discussion 
Overall the rates of product formation of the four prochiral 
substrates were significantly increased using decoy molecules 
and a generic rate accelerator variant. Using a combination of 
both methods resulted in the optimal biocatalyst in terms of 
product formation activity (PFR). The product formation rates for 
the rate accelerating mutants were higher compared to their WT 
equivalents due to a combination of superior coupling efficiency 
and NADPH activity. This presumably arises in part from them 
being in a 'catalytically ready' conformation. The inclusion of the 
perfluorinated fatty acid decoy molecules also increased the 
product formation rates. The decoy molecules are proposed to act 
in a similar fashion to the rate accelerating mutants by placing the 
enzyme in a more substrate-bound like conformation which 
enables more efficient oxidation. The decoy molecules can also 
help exclude water molecules from the active site, which could 
improve the coupling efficiency. For the substrates with lower 
activities, addition of the decoy molecule PFC10 resulted in 
improvements in variants containing the R47L/Y51F couple. This 
suggests that the decoy molecules can still effectively bind to 
these variants and facilitate substrate oxidation. It is also 
important in that this could be an effective method for improving 
the activity of related CYP102 family enzymes not all of which 
contain this pair of residues. 
The turnovers of the substrates with the shorter side chains, 
ethylbenzene and styrene, were inferior to those of n-
propylbenzene and trans-β-methylstyrene, respectively. This 
arose from a combination of lower NADPH oxidation rates and 
coupling efficiencies. The oxidation activity of the planar alkene 
substituted benzenes were also reduced compared to the 
alkylbenzene equivalents. The lower activity of the alkenes was 
predominantly due to lower coupling efficiency. Carbon-hydrogen 
bond hydroxylation is more energetically challenging than 
expoxidation suggesting that these planar substrates must be 
bound in a less favourable location in the active site compared to 
the alkylbenzenes. 
Overall n-propylbenzene oxidation proceeded with the highest 
activity, suggesting this substrate was well positioned in the active 
site for efficient CH bond abstraction. As a consequence the 
improvements observed with this substrate on addition of decoy 
molecles were reduced compared to the other substrates. The 
oxidation of n-propylbenzene is superior to ethylbenzene, toluene 
and n-butylbenzene suggesting the three carbon alkyl group is of 
the optimal size and fit for binding in the active site of P450Bm3.[6a, 
8c, 16b] The major product of alkyl benzene oxidation occurred at 
the benzylic or -position, which contain the most reactive CH 
bonds in the molecule. This contrasts with the oxidation of toluene 
and anisole which occurs predominantly at the ortho CH bond 
on the aromatic ring. While the oxidation of the more rigid styrenes 
was less active than their alkylbenzene equivalents, both resulted 
in the formation of a major single product arising from epoxidation 
of the double bond. In addition to being more active and tightly 
coupled the oxidation of n-propylbenzene and trans-β-
methylstyrene were more stereoselective than those of 
ethylbenzene and styrene. The longer alkyl or vinyl side chain 
must modify the binding orientation to place one face of the 
molecule significantly closer than the other and in a more 
favourable position for efficient oxidation. Alternatively the smaller 
substrates may be more mobile in the active site and bind in 
multiple orientations which results in the decrease in 
steroselectivity and coupling efficiency. It is of note that mutating 
the Thr438 residue to Phe, which would decrease the size of the 
active site, improves the enantioselectivity of P450Bm3 styrene 
oxidation to give (R)-styrene oxide at 64% ee.[17] 
As observed previously the regioselectivity of the oxidation 
reactions were predominantly unchanged. The largest deviation 
in the regioselectivity was observed with ethylbenzene where 
oxidation at the benzylic C-H bond (as opposed to the ortho 
aromatic site) varied from 82-94%. This infers that the substrates 
must be positioned in similar orientations in the enzyme active site 
in the presence of the decoy molecules. Changes were observed 
on the stereoselectivity of oxidation on using the rate accelerating 
mutants and the addition of the decoy molecules. The decoy 
molecules caused some turnovers to be slightly more 
stereoselective while the rate accelerating variants sometimes 
decreased the enantioselectivity. However the variation in the 
enantioselectivity for each product was generally small with the 
smaller substrates, ethylbenzene and styrene, showing greater 
changes. With trans-β-methylstyrene no substantial changes 
were observed in the enantioselectivity across the turnovers. 






Overall these observations on the relative amounts of each 
enantiomer show that while the generic rate accelerator mutants 
and the decoy molecules do not seem to alter the binding 
orientation of the substrate enough to modify the regioselectivity 
of the reactions, they can induce changes in the enantioselectivity. 
This must arise from shift in the location of the molecule in the 
active site relative to the reactive iron-oxygen species. Chiral 
decoy molecules, which have been tested with P450 
peroxygenase enzymes, may have the potential to be used for 
generate larger changes in the enantioselectivity of the 
products.[21] 
Conclusions 
The improved activity and efficiency shows that the decoy 
molecule combined with rate accelerator variants have the 
potential to improve the productivity of regio- and stereo-selective 
biocatalysis reactions. In some instances the enantiomeric 
excess was improved by the use of the decoy molecule and this 
could therefore be used as a strategy to improve the 
stereoselectivity of CH bond oxidations or alkene epoxidations. 
The combination of a rate accelerating mutant and a decoy 
molecule could also be used in conjunction with other active site 
mutations which are known to reverse the enantioselectivity of 
certain reactions.  
Experimental Section 
General 
Production and purification of full-length P450Bm3 variants for in vitro use 
was carried out as described previously..[6a,8a] General reagents and 
organics were from Sigma-Aldrich, TCI, Acros or VWR. Buffer components, 
NADPH, and isopropyl--D-thiogalactopyranoside (IPTG) were from Astral 
Scientific and Biovectra, (Scimar, Australia). UV/Vis spectroscopy was 
performed on Varian Cary 5000 or Agilent Cary 60 spectrophotometers. 
Gas chromatography mass spectrometry (GC-MS) analyses were carried 
out on a Shimadzu GC-17A instrument coupled to a QP5050A MS detector 
using a DB-5 MS fused silica column (30 m x 0.25 mm, 0.25 µm) and 
helium as the carrier gas. GC and chiral chromatography were performed 
on a Shimadzu Tracera GC coupled to Barrier discharge Ionization 
Detector (BID) detector using a RT®-BDEXse chiral silica column (Restek; 
30 m x 0.32 mm x 0.25 um) or a Supelcowax column (30 m x 0.32 mm x 
0.25 um) and helium as the carrier gas. Retention times and methods are 
given in supplementary material (Table S2). 
Activity assays 
NADPH turnovers were run in 1200 μL of 50 mM oxygenated Tris, pH 7.4 
at 30 °C, containing 0.2 μM enzyme and 120 μg bovine liver catalase. 
Assays were held at 30 °C for 1 min prior to the addition of the decoy 
molecule (100 µM) and the substrate (1 mM substrate from a 100 mM 
stock in DMSO). Finally NADPH was added, from a 20 mg mL–1 stock, to 
a final concentration of ~320 μM (equivalent to 2 AU). A period of 10 
seconds was allowed to elapse after NADPH addition before the 
absorbance decay at 340 nm was measured. The reactions were allowed 
to run until all the NADPH was consumed. The NADPH turnover rate was 
derived using ε340 = 6.22 mM−1 cm−1.  
Product analysis 
After the NADPH consumption assays were completed, 990 μL of the 
reaction mixture was mixed with 10 μL of an internal standard solution 
(trans-4-phenyl-3-buten-2-one or p-cresol, 20 mM stock solution in DMSO). 
The mixture was extracted with 400 μL of ethyl acetate and the organic 
extracts were used directly for GC-MS or GC analysis. Products were 
identified by coelution with authentic product standards or matching the 
GC-MS mass spectra to those expected for the standards (see 
supplementary material). Products were calibrated against standards 
using the assumption that isomeric products would give comparable 
responses e.g. 1-phenylethanol (α-Et) and 2-ethylphenol ((o)-Et) were 
presumed to give the same detector response. 
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